Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Harmony Biosciences Holdings, Inc. (HRMY) had Revenue of $714.73M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$714.73M
Net Income	$145.49M
Cost of Goods Sold	$156.81M
Gross Profit	$557.92M
Operating Expenses	$523.91M
Operating Income	$190.83M
Non-Operating Income/Expense	$0.98M
Pre-Tax Income	$191.80M
Normalized Pre-Tax Income	$191.80M
Income after Taxes	$145.49M
Income from Continuous Operations	$145.49M
Consolidated Net Income/Loss	$145.49M
Normalized Income after Taxes	$145.49M
EBIT	$190.83M
EBITDA	$213.38M
Weighted-Average Shares Outstanding (Basic)	56.88M
Weighted-Average Shares Outstanding (Diluted)	57.87M
Earnings per Share (EPS) (Basic)	$2.56
Earnings per Share (EPS) (Diluted)	$2.51
Balance Sheet Financials
Current Assets	$579.25M
Property, Plant, and Equipment	$1.26M
Long-Term Assets	$419.95M
Total Assets	$999.20M
Current Liabilities	$175.08M
Long-Term Debt	$163.02M
Long-Term Liabilities	$164.96M
Total Liabilities	$340.05M
Common Equity	$659.15M
Tangible Shareholders Equity	$545.89M
Shareholders Equity	$659.15M
Common Shares Outstanding	57.15M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$219.82M
Cash Flow from Investing Activities	$-67.48M
Cash Flow from Financial Activities	$-11.00M
Beginning Cash	$311.93M
End Cash	$453.27M
Increase/Decrease in Cash	$141.34M
Stock-Based Compensation	$42.60M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.31
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.20
Debt to Equity Ratio	0.27
Gross Margin	78.06%
Operating Margin	26.70%
EBIT Margin	26.70%
EBITDA Margin	29.85%
Pre-Tax Profit Margin	26.84%
Profit Margin	20.36%
Free Cash Flow	$218.67M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.72
Inventory Turnover	21.79
Receiveable Turnover	8.61
Days Sales in Receivables	42.40
Return on Equity	22.07%
Return on Tangible Equity	26.65%
Return on Assets	14.56%
Return on Investments	17.70%
Book Value Per Share	$11.53
Free Cash Flow per Share	$3.78
Operating Cash Flow per Share	$3.80

Data from Zacks Investment Research, Inc.